Drift opens exploit recovery claims with initial payouts of just over 1% of user losses
Decentralized exchange Velocity, formerly Drift, has opened claims for users who lost funds due to its April exploit, allowing them to collect recovery tokens tied to their losses.
The platform said on Thursday that users can claim one DFX token for every USDT lost. Holders then have the option of redeeming and burning their DFX for USDT from Drift's recovery pool, selling them on the secondary market, or holding them to wait for more recovery funding.
The latter option will theoretically get a user closer to full reimbursement, because as tokens are burned, newer deposits are divided among fewer DFX.
For now, each DFX can only be redeemed for a little over 0.01 USDT, the rough equivalent of getting back one cent for every dollar lost.
On Friday, Velocity's DFX redemption and recovery dashboard showed that 216,480 DFX had been redeemed for roughly 2,250 in USDT payouts. The total pool stands at 3.11 million USDT, comprised of protocol assets. Velocity will also sweep between 60% and 90% of its net protocol revenue into the recovery pool, though after the first day, that has amounted to just 31 USDT.
The dashboard had not yet recorded a contribution from Tether, which committed up to $127.5 million to support the relaunch and user recovery. Also not yet reflected was the up to $20 million pledged by strategic partners.
Asset recovery updates
The stolen assets were bridged to Ethereum, with three attacker wallets still holding 107,165 ETH worth nearly $286 million. A fourth wallet previously moved 23,094 ETH through crypto mixer Tornado Cash in July.
About $9.2 million of the stolen funds have been frozen so far, according to the foundation, which will ideally go into the DFX recovery pool once cleared by law enforcement.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-BridgeBio shares rise as FDA initiates priority review for dwarfism drug
On October 6th, shares of pharmaceutical company BridgeBio Pharma (BBIO.O) rose 2.5% in pre-market trading to $67.80. The company announced that the U.S. Food and Drug Administration (FDA) has granted priority review to its application seeking approval for the investigational oral drug infigratinib for the treatment of children with achondroplasia, the most common type of dwarfism. The FDA has set a target decision date of February 4, 2027. The application is based on a late-stage clinical trial that met both primary and key secondary endpoints; children treated with infigratinib experienced an adjusted annual growth velocity 1.74 centimeters greater than those given placebo. The drug also improved arm span and body proportions in children under eight years old. No serious adverse events or discontinuations related to the drug were reported. BridgeBio plans to apply for European approval in the fourth quarter of 2026. As of the close of the previous trading day, BBIO shares are down 13.5% year-to-date. (For the convenience of non-English speakers, Reuters has automated this report into several other languages. Because automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of automated translation, which is provided for readers’ convenience only. Reuters accepts no liability for any damages or losses arising from the use of automated translation.)
Google (GOOGL.US) spends $4.3 billions on electricity, securing 3,590 megawatts of long-term energy from Constellation Energy (CEG.US).
Google has signed a 3,590 MW power purchase agreement with Constellation Energy, with a quarter of the electricity coming from nuclear power, involving an investment of $4.3 billion.
BUZZ - Torm shares decline as Oaktree exits in a $253.5 million secondary offering
Updated Pricing Details: On October 6th, before the market opened on Tuesday, shares of the tanker operator Torm (TRMD.O), listed in the US, dropped 3.2% to $39.72 after the company announced the pricing of its secondary offering. According to the company (link), funds managed by Oaktree Capital Management sold approximately 6.3 million shares, raising a total of about $253.5 million. The secondary offering was priced at $40.05 per share, a 2.4% discount to the stock's previous closing price. According to the prospectus, Oaktree Capital completely exited its remaining approximately 6.2% stake following the sale (link). JPMorgan served as the sole underwriter for this issuance. Last month, Oaktree Capital (link) sold shares in another secondary offering of 9 million shares at $32.25 per share. Driven by record freight rates, the shares of tankers listed in Northern Europe (link) have soared, and Torm's stock closed up 2.6% on Monday at $41.05. As of Monday’s close, the company’s US-listed shares had surged about 110% year-to-date, including a 47% gain over the past three months. (For the convenience of non-English speakers, Reuters provides its report with automated translation into several languages. Due to the possibility of errors or the lack of contextual accuracy from automated translation, Reuters does not guarantee the accuracy of these texts. The automated translation is provided for readers’ convenience only. Reuters accepts no liability for any damage or loss arising from the use of automated translation features.)
BRIEF-Lamb Weston Holdings Announces Quarterly Dividend
Lamb Weston Holdings, Inc. LW.N: LAMB WESTON HOLDINGS ANNOUNCES QUARTERLY DIVIDEND LAMB WESTON HOLDINGS - DECLARES QTRLY DIVIDEND OF $0.38 PER SHARE Source text: ID:nBwWVH9na Further company coverage: LW.N
Crypto prices
More
